共 32 条
[1]
De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., Et al., European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice, Eur Heart J, 24, pp. 1601-1610, (2003)
[2]
Chobanian A.V., Bakris G.L., Black H.R., The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC7 report, JAMA, 289, pp. 2560-2572, (2003)
[3]
Atrerial hypertension andischemic heart disease. Preventive aspects, WHO Techn Rep Ser 1962
[4]
No 231, (1962)
[5]
Hetlevik I., The Role of Clinical Guidelines in Cardiovascular Risk Intervention in General Practice, (1999)
[6]
Getz L., Kirkengen A.L., Hetlevik I., Romundstad S., Sigurdsson J.A., Ethical dilemmas arising from implementation of the European guidelines on cardiovascular disease prevention in clinical practice, Scand J Prim Health Care, 22, pp. 202-208, (2004)
[7]
Tonstad S., Rosvold E.O., Furu K., Skurtveit S., Undertreatment and overtreatment with statins: The Oslo Health Study 2000-2001, J Intern Med, 255, pp. 494-502, (2004)
[8]
Tonstad S., Furu K., Rosvold E.O., Skurtveit S., Determinants of control of high blood pressure. The Oslo health study 2000-2001, Blood Pressure, 13, pp. 1-7, (2004)
[9]
Helseundersøkelsen I Hordaland
[10]
Guidelines for ATC Classification and DDD Assignment, (1998)